Synmosa Biopharma Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was TWD 760.339 million compared to TWD 786.291 million a year ago. Operating income was TWD 38.091 million compared to TWD 41.790 million a year ago. Net income was TWD 60.955 million compared to TWD 64.609 million a year ago. Basic earnings per share from continuing operations was TWD 0.23 compared to TWD 0.26 a year ago.